Canada markets open in 4 hours 51 minutes

Alligator Bioscience AB (publ) (ATORX.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
Add to watchlist
0.9620-0.0220 (-2.24%)
As of 10:36AM CEST. Market open.
Currency in SEK

Valuation Measures4

Market Cap (intraday) 647.43M
Enterprise Value 597.41M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.59
Price/Book (mrq)54.61
Enterprise Value/Revenue 10.28
Enterprise Value/EBITDA -2.51

Trading Information

Stock Price History

Beta (5Y Monthly) 1.34
52-Week Change 353.99%
S&P500 52-Week Change 325.01%
52 Week High 31.5680
52 Week Low 30.3400
50-Day Moving Average 31.0446
200-Day Moving Average 30.6924

Share Statistics

Avg Vol (3 month) 33.21M
Avg Vol (10 day) 31.19M
Shares Outstanding 5657.95M
Implied Shares Outstanding 6664.64M
Float 8414.31M
% Held by Insiders 146.56%
% Held by Institutions 14.50%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-581.61%

Management Effectiveness

Return on Assets (ttm)-108.23%
Return on Equity (ttm)-492.71%

Income Statement

Revenue (ttm)59.25M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)-41.10%
Gross Profit (ttm)N/A
EBITDA -248.24M
Net Income Avi to Common (ttm)-248.59M
Diluted EPS (ttm)-0.5500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)66.12M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)16.1M
Total Debt/Equity (mrq)135.78%
Current Ratio (mrq)0.79
Book Value Per Share (mrq)0.02

Cash Flow Statement

Operating Cash Flow (ttm)-189.28M
Levered Free Cash Flow (ttm)-100.16M